About us
How it all started – and how it took shape
Clinical Pharmacology Unit
Our CPU is located in the heart of Erfurt, the capital of Thuringia, The general set-up of the site is based on a modular system with highly flexible possibilities of adaptation to the respective phase-I or phase-II study design.
News
We are hiring!
Meet us this week at GQMA annual meeting and AGAH Mebinar
Services
All services needed for modern drug development – from full service to modules individually tailored to meet your demands!
Expertise
We are the experts at your side, interdisciplinary and with a high level of training, long work experience by our senior scientists supported by fresh enthusiasm of our junior staff. This is the setting needed for providing real expertise.
Clinical Development
Our sponsors count on us when performing clinical trials. Either with an all-around package from planning to report or with a modular approach: Always creating a tailor-made solution for you.
Publications
Latest Publication
The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference
- Publications
- The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference
- Inhibition of ovulation and pharmacologic mechanism of action of relugolix combination therapy
- Gastrointestinal tolerability of D-allulose in adults – Results of a randomised, double-blind, placebo-controlled trial
- New Ustekinumab Biosimilar Candidate FYB202: Pharmacokinetic Equivalence Demonstrated in a Randomized, Double-Blind, Parallel-Group, Single-Dose Trial in Healthy Subjects
- Skin adhesion of a newly developed, bioequivalent rotigotine patch formulation in comparison to the originator product: Results of a multi-center, randomized, crossover trial in patients with Parkinson’s disease
- Open forum conference on the ICH M13A bioequivalence guideline
- The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference
- ...
Presentations
Latest Presentation
Summary about GBHI Discussion on the BE Demonstration of Additional Strength for Solid Oral MR Products
- Presentations
- Summary about GBHI Discussion on the BE Demonstration of Additional Strength for Solid Oral MR Products
- Regulatory aspects of virtual clinical trials
- Closing Remarks of Scientific Session on BE Study Consideration for Orally Inhaled Drug Products (OIPs)
- Systemic Pharmacokinetic BE studies With and Without Blocked GI Absorption to Predict Regional Lung Exposure
- Introducion to Session 2 (BE Considerations for Modified Release (MR) Drug Products: Single Dose vs Multiple Dose Studies and Strength Waiver) Summary of Preceding GBHI Discussions on MR Drug Products including Solid Oral MR Products, Transdermal Therapeutic Systems and Long-Acting Injectables (LAI)
- Human PK studies III: interplay between biopharmaceutics and absorption
- Introduction to Session 3 (Equivalence assessment of topical products: product dependent approaches): Why the site of action matters also for topicals
- ...
Career
Our excellence is a result of our employees' relentless efforts, profound know-how and high motivation. We believe in a culture where people take pride in working together to better meet our clients needs, a culture that fosters personal growth and professional development.
Proband werden
Klinische Forschung und medizinischer Fortschritt sind ohne freiwillige Probanden, die an klinischen Studien teilnehmen, nicht möglich. Leisten Sie einen wichtigen Beitrag bei der Entwicklung von neuen und besseren Medikamenten und Therapien!